Cartesian Therapeutics (RNAC) Net Margin Growth (1y) (2016 - 2026)
Cartesian Therapeutics (RNAC) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cartesian Therapeutics | 211.08 Mn | 211.08 Mn | - | -3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.23 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Mar 31, 2025 | -140,960.00 |
| Dec 31, 2024 | 540,400.00 |
| Jun 30, 2024 | 24,587.00 |
| Mar 31, 2024 | -10,297.00 |
| Dec 31, 2023 | -241,421.00 |
| Sep 30, 2023 | -9,930.00 |
| Jun 30, 2023 | -25,093.00 |
| Mar 31, 2023 | -35,262.00 |
| Dec 31, 2022 | -579.00 |
| Sep 30, 2022 | 3,514.00 |
| Jun 30, 2022 | 3,531.00 |
| Mar 31, 2022 | 10,087.00 |
| Dec 31, 2021 | 17,013.00 |
| Sep 30, 2021 | 13,615.00 |
| Dec 31, 2020 | 4,772.00 |
| Dec 31, 2019 | 144,552.00 |
| Dec 31, 2018 | 11.33 Mn |
| Dec 31, 2017 | -11.45 Mn |